SURPASS–CVOT (Completed)
The Effect of Tirzepatide versus Dulaglutide on Major Adverse Cardiovascular Events in Patients with Type 2 Diabetes
        - Medicine
 - Tirzepatide
 - Population
 - Diabetes mellitus
 - Phase
 - III
 - Starting year
 - 2019
 - More information
 - Clinicaltrials.gov
 
